|
SNX9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.046200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.087800E-01 |
| Normal-vs-Stage2 |
1.910630E-01 |
| Normal-vs-Stage3 |
3.677000E-01 |
| Normal-vs-Stage4 |
6.965800E-01 |
| Stage1-vs-Stage2 |
1.800830E-01 |
| Stage1-vs-Stage3 |
4.227000E-01 |
| Stage1-vs-Stage4 |
8.401400E-01 |
| Stage2-vs-Stage3 |
4.885200E-01 |
| Stage2-vs-Stage4 |
3.475200E-01 |
| Stage3-vs-Stage4 |
6.926000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.214200E-01 |
| Normal-vs-AfricanAmerican |
6.128200E-01 |
| Normal-vs-Asian |
4.763600E-01 |
| Caucasian-vs-AfricanAmerican |
3.852600E-01 |
| Caucasian-vs-Asian |
2.584000E-01 |
| AfricanAmerican-vs-Asian |
9.793800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.119600E-01 |
| Normal-vs-Female |
5.971000E-01 |
| Male-vs-Female |
6.641400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.001600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.036800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.751800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.578200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.894220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.823200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.284600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.011230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.212400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.677000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.913800E-01 |
| Classical-VS-Follicular |
2.51190002131807E-09 |
| Classical-VS-Other |
1.495620E-01 |
| Classical-VS-Normal |
3.471200E-01 |
| Tall-VS-Follicular |
2.29659999999576E-05 |
| Tall-VS-Other |
6.643600E-02 |
| Tall-VS-Normal |
1.869380E-01 |
| Follicular-VS-Other |
5.910200E-01 |
| Follicular-VS-Normal |
1.554430E-04 |
| Other-VS-Normal |
1.640410E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.669600E-02 |
| Normal-vs-N1 |
8.613200E-01 |
| N0-vs-N1 |
1.440040E-01 |
|
|
